ELR-Negative CXC Chemokine CXCL11 (IP-9/I-TAC) Facilitates Dermal and Epidermal Maturation during Wound Repair

This publication has 28 references indexed in Scilit:

• Delayed and Deficient Dermal Maturation in Mice Lacking the CXCR3 ELR-Negative CXC Chemokine Receptor
  The American Journal of Pathology, 2007
• IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain
  Circulation Research, 2006
• Models of Wound Healing
  Journal of Burn Care & Rehabilitation, 2005
• Interferon-Inducible Protein 9 (CXCL11)-Induced Cell Motility in Keratinocytes Requires Calcium Flux-Dependent Activation of μ-Calpain
  Molecular and Cellular Biology, 2005
• Elevated Plasma Levels of Β-Thromboglobulin and Platelet Factor 4 in Patients with Rheumatic Disorders and Cutaneous Vasculitis
  Clinical Rheumatology, 2002
• Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain
  Molecular and Cellular Biology, 2002
• Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
  Blood, 2001
• IP-10 Inhibits Epidermal Growth Factorinduced Motility by Decreasing Epidermal Growth Factor Receptormediated Calpain Activity
  The Journal of cell biology, 1999
• Ip-10 Inhibits Epidermal Growth Factor–Induced Motility by Decreasing Epidermal Growth Factor Receptor–Mediated Calpain Activity
  The Journal of cell biology, 1999
• Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis.
  The Journal of cell biology, 1986